Project
avrg: GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for POU3F2
Z-value: 7.18
Motif logo
Transcription factors associated with POU3F2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
POU3F2
|
ENSG00000184486.10 | POU3F2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| POU3F2 | hg38_v1_chr6_+_98834560_98834582 | -0.15 | 2.2e-02 | Click! |
Activity profile of POU3F2 motif
Sorted Z-values of POU3F2 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of POU3F2
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 12.7 | 38.1 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 10.5 | 42.0 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 9.5 | 28.5 | GO:0010768 | negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010768) transmission of virus(GO:0019089) dissemination or transmission of symbiont from host(GO:0044007) dissemination or transmission of organism from other organism involved in symbiotic interaction(GO:0051821) |
| 9.2 | 27.6 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 5.6 | 16.9 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
| 5.4 | 21.4 | GO:0019860 | uracil metabolic process(GO:0019860) |
| 5.2 | 26.2 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 4.8 | 14.5 | GO:0071314 | cellular response to cocaine(GO:0071314) cellular response to luteinizing hormone stimulus(GO:0071373) |
| 4.7 | 33.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 4.5 | 17.8 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
| 4.3 | 13.0 | GO:0090149 | synaptic vesicle recycling via endosome(GO:0036466) mitochondrial membrane fission(GO:0090149) |
| 3.9 | 11.8 | GO:1902299 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) regulation of chromatin silencing at telomere(GO:0031938) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 3.9 | 30.9 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 3.7 | 14.9 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 3.7 | 14.7 | GO:0010652 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 3.7 | 11.0 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 3.3 | 16.4 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 3.2 | 25.7 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 2.9 | 11.6 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 2.8 | 11.2 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 2.8 | 13.8 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 2.7 | 8.0 | GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development(GO:0060739) |
| 2.5 | 7.6 | GO:0060221 | retinal rod cell differentiation(GO:0060221) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
| 2.4 | 7.3 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 2.4 | 7.2 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 2.4 | 7.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 2.4 | 7.1 | GO:0031456 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 2.3 | 13.9 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 2.3 | 6.8 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 2.2 | 22.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 2.2 | 8.7 | GO:0097325 | melanocyte proliferation(GO:0097325) |
| 2.1 | 6.4 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 2.1 | 8.4 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 2.0 | 17.7 | GO:2000580 | regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 1.9 | 23.2 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 1.9 | 7.6 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 1.9 | 5.6 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 1.8 | 9.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 1.8 | 9.1 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 1.8 | 10.7 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 1.7 | 24.3 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 1.7 | 22.4 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 1.7 | 6.8 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 1.7 | 33.0 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 1.6 | 6.5 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 1.6 | 11.4 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
| 1.6 | 9.8 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 1.6 | 8.0 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 1.6 | 6.3 | GO:0090096 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 1.6 | 4.7 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 1.6 | 6.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 1.5 | 9.3 | GO:0035926 | chemokine (C-C motif) ligand 2 secretion(GO:0035926) |
| 1.5 | 4.6 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 1.5 | 32.3 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 1.5 | 6.0 | GO:0051311 | meiotic metaphase I plate congression(GO:0043060) meiotic spindle midzone assembly(GO:0051257) meiotic metaphase plate congression(GO:0051311) |
| 1.5 | 4.4 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
| 1.5 | 2.9 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
| 1.5 | 13.2 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 1.5 | 8.7 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 1.4 | 4.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 1.4 | 4.3 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
| 1.4 | 7.0 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 1.4 | 4.2 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 1.4 | 18.2 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 1.3 | 5.4 | GO:0032072 | plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
| 1.3 | 9.3 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 1.3 | 6.4 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 1.3 | 3.8 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
| 1.3 | 3.8 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
| 1.3 | 6.4 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 1.3 | 3.8 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 1.3 | 5.1 | GO:0051182 | coenzyme transport(GO:0051182) |
| 1.3 | 6.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 1.3 | 6.3 | GO:1902904 | negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 1.2 | 3.7 | GO:0019878 | lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) |
| 1.2 | 7.2 | GO:0008218 | bioluminescence(GO:0008218) |
| 1.2 | 3.6 | GO:1903572 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 1.2 | 4.7 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 1.2 | 13.0 | GO:0021740 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 1.2 | 8.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 1.2 | 11.8 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 1.2 | 5.9 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 1.2 | 3.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 1.2 | 1.2 | GO:1904796 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
| 1.2 | 14.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 1.2 | 3.5 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 1.2 | 3.5 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 1.2 | 3.5 | GO:0051793 | medium-chain fatty acid catabolic process(GO:0051793) |
| 1.1 | 18.4 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 1.1 | 2.3 | GO:0090427 | activation of meiosis(GO:0090427) |
| 1.1 | 5.7 | GO:0007497 | posterior midgut development(GO:0007497) enteric smooth muscle cell differentiation(GO:0035645) |
| 1.1 | 4.3 | GO:0021836 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) regulation of negative chemotaxis(GO:0050923) |
| 1.1 | 4.3 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 1.1 | 4.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 1.0 | 5.2 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 1.0 | 7.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 1.0 | 5.2 | GO:0006574 | valine catabolic process(GO:0006574) |
| 1.0 | 8.1 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 1.0 | 14.1 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 1.0 | 6.9 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 1.0 | 14.7 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
| 1.0 | 5.9 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 1.0 | 2.9 | GO:0034092 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 1.0 | 12.5 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 1.0 | 15.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 1.0 | 2.9 | GO:1903925 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.9 | 2.8 | GO:2001045 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.9 | 3.8 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.9 | 6.6 | GO:0046985 | negative regulation of megakaryocyte differentiation(GO:0045653) positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.9 | 6.5 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.9 | 3.7 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.9 | 3.7 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.9 | 8.1 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.9 | 10.8 | GO:0009414 | response to water deprivation(GO:0009414) |
| 0.9 | 2.7 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.9 | 5.4 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
| 0.9 | 2.7 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.9 | 2.7 | GO:0097069 | response to human chorionic gonadotropin(GO:0044752) cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.9 | 5.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.9 | 6.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.9 | 0.9 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
| 0.9 | 3.5 | GO:1902576 | negative regulation of nuclear cell cycle DNA replication(GO:1902576) |
| 0.9 | 3.5 | GO:2000864 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
| 0.9 | 17.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.9 | 16.2 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.8 | 64.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.8 | 3.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.8 | 5.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.8 | 2.5 | GO:1903674 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
| 0.8 | 5.8 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.8 | 4.0 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 0.8 | 9.7 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.8 | 2.4 | GO:1903717 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) cellular response to oleic acid(GO:0071400) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
| 0.8 | 3.9 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
| 0.8 | 13.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.8 | 3.1 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.8 | 2.3 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 0.8 | 10.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.8 | 7.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.8 | 2.3 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.7 | 9.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 0.7 | 2.2 | GO:1904732 | regulation of electron carrier activity(GO:1904732) |
| 0.7 | 3.0 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.7 | 19.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.7 | 11.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.7 | 8.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.7 | 6.5 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
| 0.7 | 6.5 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.7 | 6.5 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.7 | 24.7 | GO:0045143 | homologous chromosome segregation(GO:0045143) |
| 0.7 | 9.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.7 | 8.5 | GO:0042407 | cristae formation(GO:0042407) |
| 0.7 | 1.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.7 | 2.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 0.7 | 1.4 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
| 0.7 | 8.9 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.7 | 2.0 | GO:0071934 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
| 0.7 | 5.4 | GO:0006513 | protein monoubiquitination(GO:0006513) |
| 0.7 | 15.5 | GO:0046931 | pore complex assembly(GO:0046931) |
| 0.7 | 4.7 | GO:1901896 | protein localization to nuclear pore(GO:0090204) positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.7 | 2.0 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 0.7 | 3.9 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.6 | 2.6 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.6 | 1.3 | GO:0035962 | response to interleukin-13(GO:0035962) |
| 0.6 | 4.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.6 | 10.2 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.6 | 1.9 | GO:0071038 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
| 0.6 | 43.6 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.6 | 3.8 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.6 | 5.6 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.6 | 23.7 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 0.6 | 4.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.6 | 12.9 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.6 | 1.8 | GO:0042823 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.6 | 2.4 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 0.6 | 7.1 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
| 0.6 | 3.5 | GO:0036018 | cellular response to erythropoietin(GO:0036018) |
| 0.6 | 1.2 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.6 | 3.5 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.6 | 4.1 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.6 | 2.9 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.6 | 15.0 | GO:0007052 | mitotic spindle organization(GO:0007052) |
| 0.6 | 9.2 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.6 | 1.7 | GO:1903249 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 0.6 | 3.4 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.6 | 10.7 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.6 | 0.6 | GO:1905225 | response to thyrotropin-releasing hormone(GO:1905225) |
| 0.6 | 23.0 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.6 | 4.5 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
| 0.6 | 2.2 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
| 0.6 | 6.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.6 | 8.8 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.5 | 4.3 | GO:0055129 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
| 0.5 | 3.2 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.5 | 1.6 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.5 | 3.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.5 | 3.7 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.5 | 4.2 | GO:0015865 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
| 0.5 | 4.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.5 | 1.6 | GO:1903542 | epidermal growth factor catabolic process(GO:0007174) negative regulation of exosomal secretion(GO:1903542) |
| 0.5 | 3.6 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 0.5 | 3.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.5 | 1.0 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
| 0.5 | 4.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.5 | 2.0 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
| 0.5 | 18.4 | GO:0007019 | microtubule depolymerization(GO:0007019) |
| 0.5 | 2.5 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
| 0.5 | 1.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.5 | 3.4 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.5 | 1.9 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.5 | 1.9 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.5 | 5.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.5 | 1.9 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.5 | 42.2 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
| 0.5 | 2.3 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.5 | 1.4 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.5 | 2.8 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.5 | 4.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.5 | 2.7 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.4 | 1.3 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
| 0.4 | 7.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
| 0.4 | 8.9 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.4 | 1.3 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
| 0.4 | 1.8 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.4 | 20.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.4 | 5.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.4 | 3.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.4 | 1.7 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.4 | 3.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.4 | 2.6 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.4 | 1.7 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.4 | 3.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.4 | 0.4 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
| 0.4 | 13.1 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.4 | 1.3 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.4 | 1.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.4 | 1.3 | GO:0046080 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.4 | 2.1 | GO:0016199 | microglia differentiation(GO:0014004) microglia development(GO:0014005) axon midline choice point recognition(GO:0016199) |
| 0.4 | 3.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.4 | 1.2 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
| 0.4 | 3.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.4 | 5.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.4 | 1.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.4 | 15.3 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
| 0.4 | 9.0 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
| 0.4 | 1.5 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
| 0.4 | 0.8 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.4 | 6.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.4 | 5.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.4 | 13.8 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.4 | 8.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.4 | 1.1 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.4 | 1.8 | GO:0046449 | creatinine metabolic process(GO:0046449) |
| 0.4 | 10.0 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
| 0.4 | 1.4 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.4 | 2.1 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.4 | 11.7 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.4 | 1.4 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.4 | 2.8 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.4 | 1.1 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.4 | 1.8 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.3 | 3.1 | GO:2001171 | regulation of ATP biosynthetic process(GO:2001169) positive regulation of ATP biosynthetic process(GO:2001171) |
| 0.3 | 2.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.3 | 1.0 | GO:0097698 | telomere maintenance via base-excision repair(GO:0097698) |
| 0.3 | 2.0 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.3 | 3.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 0.3 | 2.7 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.3 | 1.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.3 | 2.6 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.3 | 3.9 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.3 | 12.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.3 | 2.6 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.3 | 1.6 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.3 | 2.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.3 | 5.5 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.3 | 0.6 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) lysine transport(GO:0015819) lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine transport(GO:1902022) L-lysine import into cell(GO:1903410) |
| 0.3 | 1.9 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.3 | 3.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.3 | 1.9 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.3 | 1.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.3 | 1.6 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.3 | 7.3 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
| 0.3 | 5.0 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
| 0.3 | 2.5 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.3 | 3.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.3 | 2.8 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
| 0.3 | 2.5 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.3 | 3.7 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.3 | 3.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.3 | 0.6 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.3 | 0.6 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
| 0.3 | 3.3 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.3 | 0.9 | GO:1904692 | positive regulation of type B pancreatic cell proliferation(GO:1904692) |
| 0.3 | 2.1 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.3 | 29.3 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.3 | 7.8 | GO:0010390 | histone monoubiquitination(GO:0010390) |
| 0.3 | 7.5 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.3 | 0.9 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.3 | 5.7 | GO:0001783 | B cell apoptotic process(GO:0001783) |
| 0.3 | 1.4 | GO:0003356 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
| 0.3 | 2.2 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.3 | 3.4 | GO:0042761 | fatty acid elongation(GO:0030497) very long-chain fatty acid biosynthetic process(GO:0042761) |
| 0.3 | 2.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.3 | 1.1 | GO:0033563 | spinal cord ventral commissure morphogenesis(GO:0021965) dorsal/ventral axon guidance(GO:0033563) |
| 0.3 | 0.6 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) cellular response to lead ion(GO:0071284) |
| 0.3 | 1.4 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.3 | 2.8 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.3 | 1.6 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.3 | 1.6 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.3 | 1.9 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.3 | 1.9 | GO:0039535 | regulation of RIG-I signaling pathway(GO:0039535) |
| 0.3 | 0.5 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 0.3 | 3.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.3 | 7.4 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
| 0.3 | 12.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.3 | 3.6 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.3 | 23.8 | GO:0051225 | spindle assembly(GO:0051225) |
| 0.3 | 9.3 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
| 0.3 | 7.7 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.3 | 4.3 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.3 | 1.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.3 | 6.5 | GO:0006301 | postreplication repair(GO:0006301) |
| 0.2 | 1.5 | GO:1901727 | protein kinase D signaling(GO:0089700) positive regulation of histone deacetylase activity(GO:1901727) |
| 0.2 | 2.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.2 | 0.2 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.2 | 3.6 | GO:0050872 | white fat cell differentiation(GO:0050872) |
| 0.2 | 1.9 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
| 0.2 | 1.9 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.2 | 0.7 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
| 0.2 | 0.9 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.2 | 4.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.2 | 1.1 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.2 | 2.5 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.2 | 6.9 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.2 | 0.7 | GO:0002588 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.2 | 2.0 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.2 | 0.7 | GO:0032252 | secretory granule localization(GO:0032252) |
| 0.2 | 8.5 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
| 0.2 | 2.0 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
| 0.2 | 7.0 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.2 | 2.4 | GO:0010939 | regulation of necrotic cell death(GO:0010939) |
| 0.2 | 0.6 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.2 | 6.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.2 | 0.6 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.2 | 0.6 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.2 | 0.4 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.2 | 0.6 | GO:2000328 | regulation of T-helper 17 cell lineage commitment(GO:2000328) |
| 0.2 | 2.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.2 | 3.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.2 | 1.0 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.2 | 3.0 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.2 | 0.8 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.2 | 3.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.2 | 1.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
| 0.2 | 2.8 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.2 | 4.9 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.2 | 1.2 | GO:0050955 | thermoception(GO:0050955) |
| 0.2 | 1.2 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) positive regulation of transforming growth factor beta3 production(GO:0032916) negative regulation of lung blood pressure(GO:0061767) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.2 | 1.4 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
| 0.2 | 0.6 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.2 | 2.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.2 | 3.1 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
| 0.2 | 5.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.2 | 10.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.2 | 1.9 | GO:0042026 | protein refolding(GO:0042026) |
| 0.2 | 3.3 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.2 | 1.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 | 0.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.2 | 5.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.2 | 6.4 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.2 | 0.5 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.2 | 2.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.2 | 2.3 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
| 0.2 | 0.7 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.2 | 1.4 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
| 0.2 | 10.2 | GO:0051452 | intracellular pH reduction(GO:0051452) |
| 0.2 | 4.8 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.2 | 2.9 | GO:0042737 | drug catabolic process(GO:0042737) |
| 0.2 | 0.5 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.2 | 1.9 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.2 | 0.8 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
| 0.2 | 1.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.2 | 5.3 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.2 | 2.0 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 0.2 | 0.5 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.2 | 1.0 | GO:0098704 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.2 | 0.7 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.2 | 0.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.2 | 14.4 | GO:0006903 | vesicle targeting(GO:0006903) |
| 0.2 | 13.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.2 | 0.6 | GO:0035948 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.2 | 0.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.2 | 0.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
| 0.2 | 1.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.2 | 23.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.2 | 1.1 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.2 | 2.0 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
| 0.2 | 17.4 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.1 | 1.8 | GO:0007413 | axonal fasciculation(GO:0007413) |
| 0.1 | 1.6 | GO:0051197 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.1 | 0.9 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 | 7.4 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.1 | 1.0 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.1 | 0.4 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.1 | 0.3 | GO:0070426 | nitric oxide production involved in inflammatory response(GO:0002537) positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.1 | 0.6 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) |
| 0.1 | 3.5 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
| 0.1 | 4.8 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 | 5.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.1 | 1.2 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 | 0.5 | GO:1902938 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.1 | 1.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 2.4 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
| 0.1 | 2.9 | GO:0031103 | axon regeneration(GO:0031103) |
| 0.1 | 10.8 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.1 | 4.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.1 | 2.1 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.1 | 1.8 | GO:0090662 | ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.1 | 1.7 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.1 | 3.6 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.1 | 8.6 | GO:0021987 | cerebral cortex development(GO:0021987) |
| 0.1 | 3.2 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
| 0.1 | 0.9 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of mitotic spindle localization(GO:0040001) |
| 0.1 | 0.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.1 | 0.5 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.1 | 1.7 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 | 3.4 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.1 | 3.7 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.1 | 7.1 | GO:2000177 | regulation of neural precursor cell proliferation(GO:2000177) |
| 0.1 | 5.5 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
| 0.1 | 1.3 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
| 0.1 | 0.2 | GO:0010751 | regulation of nitric oxide mediated signal transduction(GO:0010749) negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.1 | 2.3 | GO:0048665 | neuron fate specification(GO:0048665) |
| 0.1 | 0.3 | GO:0089712 | L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
| 0.1 | 0.9 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.1 | 4.6 | GO:0009408 | response to heat(GO:0009408) |
| 0.1 | 0.8 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 | 1.8 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
| 0.1 | 1.7 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.1 | 1.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.1 | 0.6 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.1 | 2.0 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 | 0.4 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
| 0.1 | 5.9 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
| 0.1 | 7.9 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
| 0.1 | 2.0 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.1 | 0.4 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.1 | 3.0 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
| 0.1 | 0.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 | 1.6 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 0.1 | 3.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 | 2.8 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.1 | 1.7 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.1 | 1.9 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
| 0.1 | 0.5 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.1 | 0.5 | GO:0071599 | otic vesicle development(GO:0071599) |
| 0.1 | 5.1 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
| 0.1 | 0.4 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.1 | 4.0 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
| 0.1 | 1.0 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.1 | 2.6 | GO:0018126 | protein hydroxylation(GO:0018126) |
| 0.1 | 0.6 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
| 0.1 | 1.1 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
| 0.1 | 0.3 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
| 0.1 | 2.7 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
| 0.1 | 2.7 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.1 | 3.3 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.1 | 0.4 | GO:0006573 | valine metabolic process(GO:0006573) |
| 0.1 | 0.5 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.1 | 1.9 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
| 0.1 | 0.3 | GO:0039007 | positive regulation of polarized epithelial cell differentiation(GO:0030862) pronephric nephron morphogenesis(GO:0039007) pronephric nephron tubule morphogenesis(GO:0039008) pronephric duct development(GO:0039022) pronephric duct morphogenesis(GO:0039023) specification of axis polarity(GO:0065001) Kupffer's vesicle development(GO:0070121) |
| 0.1 | 0.6 | GO:0061709 | reticulophagy(GO:0061709) |
| 0.1 | 1.1 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.1 | 0.2 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.1 | 1.5 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 | 0.3 | GO:2001206 | positive regulation of bone development(GO:1903012) positive regulation of osteoclast development(GO:2001206) |
| 0.1 | 0.8 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.1 | 0.4 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.1 | 0.9 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.1 | 2.9 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.1 | 0.5 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
| 0.1 | 0.3 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
| 0.1 | 0.4 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.1 | 0.3 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
| 0.1 | 3.1 | GO:0048709 | oligodendrocyte differentiation(GO:0048709) |
| 0.1 | 0.2 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) |
| 0.1 | 4.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.1 | 0.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.1 | 8.4 | GO:0090002 | establishment of protein localization to plasma membrane(GO:0090002) |
| 0.1 | 4.8 | GO:0045333 | cellular respiration(GO:0045333) |
| 0.1 | 4.1 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
| 0.1 | 0.6 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
| 0.1 | 1.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.1 | 1.1 | GO:0032402 | melanosome transport(GO:0032402) |
| 0.1 | 4.6 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
| 0.1 | 1.1 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
| 0.1 | 2.2 | GO:0071806 | protein transmembrane transport(GO:0071806) |
| 0.1 | 1.2 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
| 0.1 | 1.9 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 0.1 | 0.5 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.1 | 1.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 | 1.1 | GO:0051923 | sulfation(GO:0051923) |
| 0.1 | 4.0 | GO:0019827 | stem cell population maintenance(GO:0019827) |
| 0.1 | 0.7 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.0 | 0.2 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.0 | 0.2 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.0 | 0.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.0 | 0.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 | 0.5 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.0 | 0.6 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.0 | 0.1 | GO:0018282 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.0 | 0.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.0 | 0.5 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.0 | 3.1 | GO:0042752 | regulation of circadian rhythm(GO:0042752) |
| 0.0 | 3.5 | GO:0006457 | protein folding(GO:0006457) |
| 0.0 | 1.7 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.0 | 0.6 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
| 0.0 | 1.8 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
| 0.0 | 0.2 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.0 | 2.0 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
| 0.0 | 1.0 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
| 0.0 | 0.6 | GO:0045931 | positive regulation of mitotic cell cycle(GO:0045931) |
| 0.0 | 0.1 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.0 | 0.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.0 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
| 0.0 | 1.8 | GO:0000910 | cytokinesis(GO:0000910) |
| 0.0 | 1.4 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.0 | 0.2 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.0 | 3.4 | GO:0007018 | microtubule-based movement(GO:0007018) |
| 0.0 | 0.8 | GO:0051781 | positive regulation of cell division(GO:0051781) |
| 0.0 | 0.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.0 | 0.2 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
| 0.0 | 0.3 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 0.0 | 0.7 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.0 | 0.5 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.0 | 0.4 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
| 0.0 | 2.0 | GO:0031424 | keratinization(GO:0031424) |
| 0.0 | 0.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
| 0.0 | 0.6 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.0 | 0.2 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.0 | 0.2 | GO:0006706 | steroid catabolic process(GO:0006706) |
| 0.0 | 0.3 | GO:0021954 | central nervous system neuron development(GO:0021954) |
| 0.0 | 0.4 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.0 | 1.4 | GO:0033559 | unsaturated fatty acid metabolic process(GO:0033559) |
| 0.0 | 0.0 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.0 | 0.2 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.0 | 0.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.0 | 0.2 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
| 0.0 | 0.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.0 | 0.6 | GO:0001764 | neuron migration(GO:0001764) |
| 0.0 | 0.2 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.0 | 0.2 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.0 | 15.0 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 4.8 | 19.1 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 4.2 | 25.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 3.9 | 11.8 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 3.6 | 14.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 3.4 | 13.4 | GO:0071920 | cleavage body(GO:0071920) |
| 3.1 | 27.6 | GO:0036449 | microtubule minus-end(GO:0036449) meiotic spindle(GO:0072687) |
| 2.9 | 17.5 | GO:0001940 | male pronucleus(GO:0001940) |
| 2.9 | 11.5 | GO:0000811 | GINS complex(GO:0000811) |
| 2.7 | 16.4 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 2.7 | 8.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 2.3 | 13.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 2.1 | 14.5 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 2.0 | 6.0 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 1.9 | 17.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 1.9 | 9.4 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 1.8 | 9.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 1.7 | 6.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 1.6 | 16.0 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 1.5 | 12.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 1.5 | 51.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 1.5 | 7.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 1.5 | 6.0 | GO:0005715 | late recombination nodule(GO:0005715) |
| 1.4 | 8.5 | GO:0061617 | MICOS complex(GO:0061617) |
| 1.4 | 16.8 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 1.4 | 6.9 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 1.3 | 3.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 1.3 | 36.2 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 1.3 | 7.7 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 1.3 | 5.1 | GO:0071986 | Ragulator complex(GO:0071986) |
| 1.2 | 8.7 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 1.2 | 9.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 1.2 | 22.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 1.2 | 5.9 | GO:0001651 | dense fibrillar component(GO:0001651) |
| 1.2 | 3.5 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
| 1.1 | 14.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 1.1 | 31.1 | GO:0043218 | compact myelin(GO:0043218) |
| 1.1 | 7.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 1.1 | 4.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 1.1 | 7.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 1.1 | 7.4 | GO:0043203 | axon hillock(GO:0043203) |
| 1.1 | 6.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 1.0 | 5.1 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
| 1.0 | 12.9 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 1.0 | 3.0 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 1.0 | 6.9 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 1.0 | 14.7 | GO:0043219 | lateral loop(GO:0043219) |
| 1.0 | 2.9 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 1.0 | 10.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
| 0.9 | 17.0 | GO:0005922 | connexon complex(GO:0005922) |
| 0.9 | 13.0 | GO:0090543 | Flemming body(GO:0090543) |
| 0.9 | 9.1 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.9 | 6.4 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
| 0.9 | 2.7 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.9 | 6.2 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.9 | 5.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 0.8 | 21.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.8 | 11.6 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.8 | 2.4 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.8 | 9.7 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.8 | 7.2 | GO:0034709 | methylosome(GO:0034709) |
| 0.8 | 2.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.8 | 6.3 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.8 | 10.0 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.8 | 41.0 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.7 | 9.0 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.7 | 6.6 | GO:0045120 | pronucleus(GO:0045120) |
| 0.7 | 2.9 | GO:0035363 | histone locus body(GO:0035363) |
| 0.7 | 3.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.7 | 11.5 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
| 0.7 | 2.8 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.7 | 11.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.7 | 2.1 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.7 | 8.9 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.7 | 11.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.7 | 2.6 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.7 | 7.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.7 | 10.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.7 | 7.2 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.7 | 13.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.6 | 24.3 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.6 | 10.4 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.6 | 3.0 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.6 | 6.7 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.6 | 4.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.6 | 1.8 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.6 | 4.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.6 | 7.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.6 | 3.5 | GO:0070187 | telosome(GO:0070187) |
| 0.6 | 3.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.5 | 10.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.5 | 6.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.5 | 5.3 | GO:0051286 | cell tip(GO:0051286) |
| 0.5 | 1.6 | GO:0032419 | extrinsic component of lysosome membrane(GO:0032419) |
| 0.5 | 3.5 | GO:0043196 | varicosity(GO:0043196) |
| 0.5 | 29.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.5 | 3.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.5 | 2.4 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.5 | 5.4 | GO:0005638 | lamin filament(GO:0005638) |
| 0.5 | 2.4 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.5 | 5.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.5 | 5.9 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.4 | 1.3 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.4 | 25.4 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.4 | 0.9 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.4 | 1.7 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 0.4 | 5.5 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
| 0.4 | 9.7 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.4 | 3.7 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.4 | 3.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.4 | 1.2 | GO:0033593 | BRCA2-MAGE-D1 complex(GO:0033593) |
| 0.4 | 1.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.4 | 2.0 | GO:0005828 | kinetochore microtubule(GO:0005828) postsynaptic recycling endosome(GO:0098837) |
| 0.4 | 44.8 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.4 | 2.0 | GO:0032807 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
| 0.4 | 1.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.4 | 2.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 0.4 | 1.9 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 0.4 | 5.4 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
| 0.4 | 4.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.4 | 6.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.4 | 3.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.4 | 3.3 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.4 | 6.7 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.3 | 9.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.3 | 1.4 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.3 | 7.2 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.3 | 5.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.3 | 13.6 | GO:0016592 | mediator complex(GO:0016592) |
| 0.3 | 11.9 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.3 | 8.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.3 | 9.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.3 | 12.5 | GO:0043034 | costamere(GO:0043034) |
| 0.3 | 5.2 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.3 | 3.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.3 | 2.6 | GO:0032059 | bleb(GO:0032059) |
| 0.3 | 10.1 | GO:0002102 | podosome(GO:0002102) |
| 0.3 | 1.2 | GO:0060091 | kinocilium(GO:0060091) |
| 0.3 | 1.1 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.3 | 2.0 | GO:0032021 | NELF complex(GO:0032021) |
| 0.3 | 2.8 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.3 | 3.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.3 | 4.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.3 | 5.2 | GO:0036038 | MKS complex(GO:0036038) |
| 0.3 | 30.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.3 | 0.8 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.3 | 2.6 | GO:0043073 | male germ cell nucleus(GO:0001673) germ cell nucleus(GO:0043073) |
| 0.3 | 5.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.3 | 2.0 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.3 | 17.3 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
| 0.3 | 3.0 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.2 | 23.7 | GO:0005604 | basement membrane(GO:0005604) |
| 0.2 | 1.2 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.2 | 21.5 | GO:0000793 | condensed chromosome(GO:0000793) |
| 0.2 | 1.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.2 | 5.3 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
| 0.2 | 8.1 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.2 | 19.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.2 | 1.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.2 | 0.7 | GO:1990462 | omegasome(GO:1990462) |
| 0.2 | 73.2 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.2 | 0.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.2 | 1.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.2 | 6.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.2 | 10.0 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.2 | 1.9 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.2 | 0.2 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.2 | 23.4 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.2 | 0.6 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
| 0.2 | 4.1 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.2 | 1.0 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.2 | 5.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.2 | 9.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.2 | 1.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.2 | 2.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.2 | 0.9 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.2 | 55.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.2 | 2.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.2 | 1.4 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.2 | 2.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.2 | 24.3 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.2 | 1.2 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.2 | 2.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.2 | 2.7 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.2 | 1.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.2 | 56.3 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.2 | 3.0 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.2 | 19.0 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.2 | 2.0 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.1 | 1.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.1 | 0.6 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.1 | 1.5 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.1 | 0.7 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.1 | 1.0 | GO:0005921 | gap junction(GO:0005921) |
| 0.1 | 0.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.1 | 33.6 | GO:0005819 | spindle(GO:0005819) |
| 0.1 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.1 | 4.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 6.0 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
| 0.1 | 3.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.1 | 0.4 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.1 | 1.8 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.1 | 0.7 | GO:0000243 | commitment complex(GO:0000243) |
| 0.1 | 1.0 | GO:0097433 | dense body(GO:0097433) |
| 0.1 | 0.7 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.1 | 0.4 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.1 | 1.7 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 0.1 | 0.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.1 | 1.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.1 | 10.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.1 | 3.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.1 | 0.5 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.1 | 0.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 9.5 | GO:0005903 | brush border(GO:0005903) |
| 0.1 | 0.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.1 | 2.6 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.1 | 29.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.1 | 1.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.1 | 1.7 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.1 | 0.2 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.1 | 1.7 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.1 | 0.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.1 | 5.2 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.1 | 1.8 | GO:0005844 | polysome(GO:0005844) |
| 0.1 | 0.6 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.1 | 1.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.1 | 1.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 3.8 | GO:0016234 | inclusion body(GO:0016234) |
| 0.1 | 4.5 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 2.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.1 | 0.6 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.1 | 4.3 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
| 0.0 | 0.3 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.0 | 1.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.0 | 1.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.0 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.0 | 0.6 | GO:0031932 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
| 0.0 | 0.8 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.0 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
| 0.0 | 1.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.0 | 0.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.0 | 0.3 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.0 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
| 0.0 | 1.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.0 | 0.2 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.0 | 0.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.0 | 1.2 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 7.5 | GO:0005925 | cell-substrate adherens junction(GO:0005924) focal adhesion(GO:0005925) |
| 0.0 | 0.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 0.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.0 | 0.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.0 | 13.5 | GO:0005730 | nucleolus(GO:0005730) |
| 0.0 | 0.3 | GO:0030673 | axolemma(GO:0030673) |
| 0.0 | 1.6 | GO:0043197 | dendritic spine(GO:0043197) |
| 0.0 | 1.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.0 | 0.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.0 | 42.0 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 5.3 | 36.9 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
| 4.4 | 17.4 | GO:0070404 | NADH binding(GO:0070404) |
| 4.2 | 16.9 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
| 4.2 | 12.5 | GO:0004639 | phosphoribosylaminoimidazole carboxylase activity(GO:0004638) phosphoribosylaminoimidazolesuccinocarboxamide synthase activity(GO:0004639) |
| 4.1 | 28.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 3.7 | 11.0 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 2.9 | 11.6 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 2.8 | 11.3 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
| 2.8 | 8.3 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 2.6 | 2.6 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
| 2.6 | 7.7 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 2.5 | 14.7 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
| 2.3 | 16.4 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 2.3 | 9.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 2.3 | 6.9 | GO:0003860 | 3-hydroxyisobutyryl-CoA hydrolase activity(GO:0003860) |
| 2.1 | 31.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 2.1 | 4.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 2.1 | 18.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 1.9 | 7.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 1.8 | 7.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 1.8 | 5.5 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 1.8 | 16.0 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 1.8 | 26.7 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 1.8 | 5.3 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 1.7 | 36.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 1.7 | 17.4 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 1.7 | 13.8 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 1.7 | 22.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 1.7 | 25.6 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 1.7 | 6.6 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
| 1.6 | 42.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 1.6 | 25.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 1.5 | 12.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 1.5 | 27.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 1.5 | 14.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) RNA strand annealing activity(GO:0033592) |
| 1.5 | 4.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 1.4 | 14.3 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 1.4 | 7.0 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 1.4 | 11.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 1.4 | 8.3 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 1.3 | 5.4 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
| 1.3 | 6.5 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 1.3 | 3.8 | GO:0034512 | box C/D snoRNA binding(GO:0034512) |
| 1.3 | 3.8 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 1.3 | 17.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 1.3 | 8.8 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 1.2 | 9.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 1.2 | 5.9 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 1.2 | 5.8 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 1.2 | 3.5 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 1.1 | 3.4 | GO:0003896 | DNA primase activity(GO:0003896) |
| 1.1 | 3.3 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 1.1 | 5.6 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 1.1 | 6.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 1.1 | 6.6 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 1.1 | 7.6 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 1.1 | 4.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 1.1 | 4.2 | GO:0043515 | kinetochore binding(GO:0043515) |
| 1.0 | 10.1 | GO:0005549 | odorant binding(GO:0005549) |
| 1.0 | 8.0 | GO:0045545 | syndecan binding(GO:0045545) |
| 1.0 | 4.9 | GO:0016936 | galactoside binding(GO:0016936) |
| 1.0 | 3.9 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 1.0 | 2.9 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 1.0 | 10.7 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 1.0 | 27.1 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 1.0 | 2.9 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 1.0 | 12.5 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 1.0 | 7.7 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.9 | 10.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.9 | 9.3 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.9 | 5.6 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.9 | 20.3 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.9 | 11.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.9 | 3.7 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.9 | 5.4 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.9 | 7.2 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.9 | 6.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.9 | 2.7 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.9 | 6.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.8 | 3.3 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.8 | 4.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.8 | 14.7 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.8 | 2.4 | GO:0035651 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
| 0.8 | 5.7 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.8 | 4.0 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.8 | 20.6 | GO:0001848 | complement binding(GO:0001848) |
| 0.8 | 42.6 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.8 | 35.6 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 0.8 | 5.4 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
| 0.8 | 2.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.7 | 18.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.7 | 2.2 | GO:0016531 | copper chaperone activity(GO:0016531) |
| 0.7 | 2.2 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.7 | 3.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.7 | 2.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.7 | 4.5 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.7 | 7.4 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.7 | 3.0 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.7 | 4.4 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.7 | 3.6 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.7 | 4.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.7 | 2.8 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.7 | 3.5 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 0.7 | 2.0 | GO:0015563 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) uptake transmembrane transporter activity(GO:0015563) |
| 0.7 | 3.3 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.7 | 2.0 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.6 | 1.9 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.6 | 3.9 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.6 | 5.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.6 | 3.1 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.6 | 12.9 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.6 | 1.8 | GO:0031403 | lithium ion binding(GO:0031403) |
| 0.6 | 4.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.6 | 3.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.6 | 2.4 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.6 | 3.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.6 | 8.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.6 | 3.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.6 | 16.3 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.6 | 20.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.6 | 1.7 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 0.6 | 6.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.6 | 9.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.6 | 13.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.5 | 3.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.5 | 4.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.5 | 4.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.5 | 13.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.5 | 1.6 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
| 0.5 | 10.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.5 | 25.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.5 | 2.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.5 | 13.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.5 | 3.0 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.5 | 2.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.5 | 5.5 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
| 0.5 | 1.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
| 0.5 | 6.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.5 | 6.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.5 | 2.8 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.5 | 3.7 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.5 | 2.8 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.5 | 16.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.5 | 1.4 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.4 | 4.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.4 | 4.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.4 | 7.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.4 | 3.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.4 | 8.0 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.4 | 11.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.4 | 5.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.4 | 1.3 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.4 | 2.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.4 | 3.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.4 | 1.6 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 0.4 | 2.8 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.4 | 7.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.4 | 1.6 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.4 | 9.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.4 | 3.1 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.4 | 6.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 0.4 | 5.3 | GO:0050542 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
| 0.4 | 17.7 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.4 | 1.9 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.4 | 1.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.4 | 4.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.4 | 2.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.4 | 1.1 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
| 0.3 | 9.7 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.3 | 14.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.3 | 1.0 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
| 0.3 | 24.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.3 | 1.4 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.3 | 2.4 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.3 | 2.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.3 | 2.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.3 | 2.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.3 | 4.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.3 | 5.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.3 | 1.0 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.3 | 6.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.3 | 2.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
| 0.3 | 10.1 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.3 | 2.9 | GO:0089720 | caspase binding(GO:0089720) |
| 0.3 | 1.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
| 0.3 | 1.6 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.3 | 1.3 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.3 | 7.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.3 | 10.8 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.3 | 16.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.3 | 1.9 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.3 | 4.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.3 | 13.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.3 | 0.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.3 | 22.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.3 | 1.2 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
| 0.3 | 2.1 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.3 | 0.9 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.3 | 0.9 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 0.3 | 15.5 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.3 | 2.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.3 | 0.9 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
| 0.3 | 6.5 | GO:0031005 | filamin binding(GO:0031005) |
| 0.3 | 7.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.3 | 1.9 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) ATP transmembrane transporter activity(GO:0005347) purine nucleotide transmembrane transporter activity(GO:0015216) ADP transmembrane transporter activity(GO:0015217) |
| 0.3 | 0.8 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.3 | 8.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.3 | 0.8 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.3 | 0.8 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.3 | 2.1 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.3 | 12.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) cis-trans isomerase activity(GO:0016859) |
| 0.3 | 1.0 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.3 | 3.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.3 | 1.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.2 | 0.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.2 | 2.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.2 | 1.7 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.2 | 8.8 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.2 | 7.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.2 | 1.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.2 | 13.3 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
| 0.2 | 3.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.2 | 0.9 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.2 | 0.9 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.2 | 2.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.2 | 5.7 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.2 | 1.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.2 | 19.3 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.2 | 1.0 | GO:0052843 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.2 | 0.8 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.2 | 2.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.2 | 4.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.2 | 5.7 | GO:0042166 | acetylcholine-gated cation channel activity(GO:0022848) acetylcholine binding(GO:0042166) |
| 0.2 | 0.6 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
| 0.2 | 1.0 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.2 | 1.9 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
| 0.2 | 17.3 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.2 | 0.9 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.2 | 5.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.2 | 4.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.2 | 3.6 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.2 | 7.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.2 | 1.8 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.2 | 2.1 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.2 | 1.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.2 | 2.1 | GO:0004659 | prenyltransferase activity(GO:0004659) |
| 0.2 | 0.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.2 | 1.0 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.2 | 1.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.2 | 3.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.2 | 7.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.2 | 1.0 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) fructose binding(GO:0070061) |
| 0.2 | 4.2 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.2 | 4.1 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
| 0.2 | 2.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.2 | 2.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.2 | 1.2 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.2 | 2.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.2 | 1.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.2 | 0.6 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.2 | 17.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 3.8 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.1 | 2.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.1 | 10.5 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.1 | 27.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.1 | 0.7 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.1 | 1.0 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.1 | 11.3 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.1 | 1.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.1 | 2.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.1 | 25.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
| 0.1 | 1.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.1 | 1.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
| 0.1 | 4.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.1 | 0.4 | GO:0036505 | prosaposin receptor activity(GO:0036505) |
| 0.1 | 3.3 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
| 0.1 | 1.5 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 2.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.1 | 25.2 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.1 | 0.4 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.1 | 3.2 | GO:0046961 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.1 | 5.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 0.2 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.1 | 1.6 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.1 | 0.7 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.1 | 1.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.1 | 1.0 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
| 0.1 | 1.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.1 | 4.6 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
| 0.1 | 1.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.1 | 39.8 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.1 | 3.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.1 | 0.3 | GO:0033989 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
| 0.1 | 0.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.1 | 0.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.1 | 3.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.1 | 0.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 0.1 | 1.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.1 | 2.4 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.1 | 1.3 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 0.1 | 0.5 | GO:1900750 | oligopeptide binding(GO:1900750) |
| 0.1 | 0.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.1 | 1.9 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.1 | 1.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.1 | 0.5 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.1 | 10.2 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 0.1 | 1.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 0.1 | 1.1 | GO:0016594 | glycine binding(GO:0016594) |
| 0.1 | 4.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.1 | 0.4 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.1 | 5.2 | GO:0005254 | chloride channel activity(GO:0005254) |
| 0.1 | 0.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.1 | 0.6 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.1 | 0.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.1 | 3.3 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.1 | 16.8 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.1 | 0.6 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.1 | 2.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.1 | 4.8 | GO:0051219 | phosphoprotein binding(GO:0051219) |
| 0.1 | 0.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.1 | 7.5 | GO:0002020 | protease binding(GO:0002020) |
| 0.1 | 2.0 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.1 | 0.5 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.1 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.1 | 1.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.1 | 0.5 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.1 | 0.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.1 | 2.0 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.1 | 0.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.1 | 0.7 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.1 | 0.7 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.1 | 2.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.0 | 0.2 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
| 0.0 | 0.1 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.0 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.0 | 0.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.0 | 4.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 2.0 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.0 | 0.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.0 | 7.6 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.0 | 2.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.0 | 0.4 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.0 | 0.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.0 | 0.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.0 | 0.1 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.0 | 0.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.0 | 2.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.0 | 1.4 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
| 0.0 | 0.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.0 | 0.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
| 0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.0 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.0 | 2.7 | GO:0008201 | heparin binding(GO:0008201) |
| 0.0 | 0.1 | GO:0016497 | substance K receptor activity(GO:0016497) |
| 0.0 | 0.3 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.0 | 0.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.0 | 0.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.0 | 0.1 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.9 | 40.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 1.1 | 3.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 1.0 | 44.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.9 | 53.6 | PID ATR PATHWAY | ATR signaling pathway |
| 0.8 | 17.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.7 | 18.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.6 | 11.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.6 | 18.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.6 | 29.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.5 | 32.2 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.5 | 7.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.5 | 29.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.5 | 17.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.4 | 11.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.4 | 32.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.4 | 14.0 | PID ATM PATHWAY | ATM pathway |
| 0.4 | 20.1 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.4 | 6.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.4 | 3.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.3 | 12.8 | PID MYC PATHWAY | C-MYC pathway |
| 0.3 | 24.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.3 | 7.7 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.3 | 12.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.3 | 6.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.3 | 4.5 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.2 | 9.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.2 | 11.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.2 | 6.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.2 | 4.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.2 | 9.0 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.2 | 11.0 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.2 | 5.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.2 | 11.6 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.2 | 16.3 | PID E2F PATHWAY | E2F transcription factor network |
| 0.2 | 5.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.2 | 7.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.2 | 0.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.2 | 2.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.1 | 5.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 7.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 8.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 0.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 3.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 1.5 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.1 | 1.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.1 | 1.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 2.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.1 | 3.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.1 | 3.4 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 0.1 | 3.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.1 | 1.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.1 | 3.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.1 | 2.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 2.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.1 | 1.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 4.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 1.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 3.7 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.1 | 3.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.1 | 2.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.1 | 4.8 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.1 | 2.6 | PID FGF PATHWAY | FGF signaling pathway |
| 0.1 | 2.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.1 | 3.0 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.1 | 10.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.1 | 1.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.1 | 3.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.1 | 1.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.1 | 3.1 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.1 | 0.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 0.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.1 | 3.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.1 | 1.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.0 | 2.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 0.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.0 | 0.5 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.0 | 0.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.0 | 0.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.0 | 0.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.0 | 3.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 0.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.0 | 0.3 | PID LKB1 PATHWAY | LKB1 signaling events |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.8 | 25.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 2.1 | 62.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 1.7 | 64.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 1.6 | 23.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 1.5 | 9.3 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
| 1.5 | 22.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 1.4 | 25.3 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 1.1 | 21.8 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.9 | 17.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.9 | 88.8 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
| 0.9 | 6.2 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
| 0.9 | 23.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.9 | 7.7 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
| 0.8 | 7.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.8 | 9.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.8 | 62.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.8 | 25.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.8 | 30.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.7 | 7.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.7 | 11.6 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.7 | 14.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.7 | 8.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.7 | 3.4 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
| 0.7 | 19.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.7 | 36.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.6 | 7.9 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.6 | 20.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.6 | 14.5 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.6 | 8.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.6 | 22.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.5 | 8.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.5 | 14.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.5 | 19.6 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.5 | 27.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.5 | 26.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.5 | 9.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.5 | 9.5 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.5 | 5.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.5 | 6.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.5 | 8.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.5 | 5.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.5 | 43.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.5 | 9.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.5 | 3.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.4 | 3.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.4 | 8.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.4 | 12.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.4 | 6.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.4 | 7.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.4 | 11.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.4 | 5.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.4 | 7.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.4 | 20.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.4 | 6.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.4 | 4.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.3 | 18.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.3 | 8.5 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.3 | 13.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.3 | 3.0 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
| 0.3 | 25.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.3 | 12.5 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 0.3 | 33.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.3 | 2.5 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.3 | 5.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.3 | 8.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.3 | 4.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.3 | 1.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.3 | 0.3 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.3 | 5.7 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.3 | 8.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.3 | 3.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.3 | 11.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.2 | 20.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.2 | 9.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.2 | 2.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.2 | 3.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.2 | 17.5 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
| 0.2 | 4.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.2 | 4.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.2 | 0.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
| 0.2 | 2.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.2 | 2.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.2 | 5.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.2 | 4.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.2 | 4.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.2 | 7.7 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.2 | 3.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.2 | 2.0 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.2 | 4.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.1 | 1.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 3.6 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.1 | 2.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.1 | 0.7 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 0.1 | 2.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.1 | 6.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 1.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.1 | 4.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 4.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.1 | 2.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 2.0 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.1 | 2.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.1 | 1.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.1 | 3.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 2.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.1 | 2.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 3.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.1 | 2.0 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.1 | 1.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
| 0.1 | 4.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
| 0.1 | 13.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.1 | 2.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.1 | 5.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.1 | 2.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.1 | 1.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.1 | 1.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.1 | 3.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 0.9 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.1 | 13.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.1 | 2.5 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 0.1 | 2.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.1 | 3.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.1 | 1.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.1 | 2.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 5.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 0.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.1 | 1.2 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
| 0.1 | 11.4 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.1 | 1.4 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
| 0.1 | 6.3 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.1 | 1.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.1 | 1.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.1 | 0.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.1 | 0.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.1 | 4.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.1 | 1.0 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
| 0.0 | 1.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.0 | 0.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.0 | 1.5 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.0 | 0.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.0 | 1.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.0 | 1.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.0 | 0.4 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.0 | 1.2 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
| 0.0 | 0.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.0 | 1.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.0 | 0.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.0 | 1.4 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.0 | 3.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.0 | 0.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |